Ciribilli Y - Search Results

1

Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer.

Ferro A, Campora M, Caldara A, De Lisi D, Lorenzi M, Monteverdi S, Mihai R, Bisio A, Dipasquale M, Caffo O, Ciribilli Y. Ferro A, et al. Among authors: ciribilli y. J Clin Med. 2024 Jun 20;13(12):3611. doi: 10.3390/jcm13123611. J Clin Med. 2024. PMID: 38930141 Free PMC article. Review.

2

Transcriptional properties of feline p53 and its tumour-associated mutants: a yeast-based approach.

Cardellino U, Ciribilli Y, Andreotti V, Modesto P, Menichini P, Fronza G, Pellegrino C, Inga A. Cardellino U, et al. Among authors: ciribilli y. Mutagenesis. 2007 Nov;22(6):417-23. doi: 10.1093/mutage/gem038. Epub 2007 Oct 18. Mutagenesis. 2007. PMID: 17947339

3

A functional genetic study identifies HAND1 mutations in septation defects of the human heart.

Reamon-Buettner SM, Ciribilli Y, Traverso I, Kuhls B, Inga A, Borlak J. Reamon-Buettner SM, et al. Among authors: ciribilli y. Hum Mol Genet. 2009 Oct 1;18(19):3567-78. doi: 10.1093/hmg/ddp305. Epub 2009 Jul 7. Hum Mol Genet. 2009. PMID: 19586923

4

Tumour p53 mutations exhibit promoter selective dominance over wild type p53.

Monti P, Campomenosi P, Ciribilli Y, Iannone R, Inga A, Abbondandolo A, Resnick MA, Fronza G. Monti P, et al. Among authors: ciribilli y. Oncogene. 2002 Mar 7;21(11):1641-8. doi: 10.1038/sj.onc.1205250. Oncogene. 2002. PMID: 11896595

5

The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound.

Ciribilli Y, Andreotti V, Menendez D, Langen JS, Schoenfelder G, Resnick MA, Inga A. Ciribilli Y, et al. PLoS One. 2010 Apr 21;5(4):e10236. doi: 10.1371/journal.pone.0010236. PLoS One. 2010. PMID: 20422012 Free PMC article.

6

p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system.

Andreotti V, Ciribilli Y, Monti P, Bisio A, Lion M, Jordan J, Fronza G, Menichini P, Resnick MA, Inga A. Andreotti V, et al. Among authors: ciribilli y. PLoS One. 2011;6(6):e20643. doi: 10.1371/journal.pone.0020643. Epub 2011 Jun 2. PLoS One. 2011. PMID: 21674059 Free PMC article.

7

Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics.

Lion M, Bisio A, Tebaldi T, De Sanctis V, Menendez D, Resnick MA, Ciribilli Y, Inga A. Lion M, et al. Among authors: ciribilli y. Cell Cycle. 2013 Apr 15;12(8):1211-24. doi: 10.4161/cc.24309. Epub 2013 Mar 21. Cell Cycle. 2013. PMID: 23518503 Free PMC article.

8

Identification of new p53 target microRNAs by bioinformatics and functional analysis.

Bisio A, De Sanctis V, Del Vescovo V, Denti MA, Jegga AG, Inga A, Ciribilli Y. Bisio A, et al. Among authors: ciribilli y. BMC Cancer. 2013 Nov 21;13:552. doi: 10.1186/1471-2407-13-552. BMC Cancer. 2013. PMID: 24256616 Free PMC article.

9

TP53 mutants in the tower of babel of cancer progression.

Bisio A, Ciribilli Y, Fronza G, Inga A, Monti P. Bisio A, et al. Among authors: ciribilli y. Hum Mutat. 2014 Jun;35(6):689-701. doi: 10.1002/humu.22514. Epub 2014 Mar 14. Hum Mutat. 2014. PMID: 24449472

10

p53-directed translational control can shape and expand the universe of p53 target genes.

Zaccara S, Tebaldi T, Pederiva C, Ciribilli Y, Bisio A, Inga A. Zaccara S, et al. Among authors: ciribilli y. Cell Death Differ. 2014 Oct;21(10):1522-34. doi: 10.1038/cdd.2014.79. Epub 2014 Jun 13. Cell Death Differ. 2014. PMID: 24926617 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters